RYTM - Rhythm Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

RYTM is currently covered by 11 analysts with an average price target of $76.56. This is a potential upside of $16.72 (27.94%) from yesterday's end of day stock price of $59.84.

Rhythm Pharmaceuticals's activity chart (see below) currently has 65 price targets and 107 ratings on display. The stock rating distribution of RYTM is 11.48% HOLD and 88.52% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 70.85% with an average time for these price targets to be met of 364.71 days.

Highest price target for RYTM is $92, Lowest price target is $65, average price target is $73.45.

Most recent stock forecast was given by TAZEEN AHMAD from BAML on 10-Apr-2025. First documented stock forecast 30-Oct-2017.

Currently out of the existing stock ratings of RYTM, 7 are a HOLD (11.48%), 54 are a BUY (88.52%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$68

$6.26 (10.14%)

$63

14 days ago
(10-Apr-2025)

11/13 (84.62%)

$10.17 (17.59%)

176

Buy

$66

$4.26 (6.90%)

$66

16 days ago
(08-Apr-2025)

15/20 (75%)

$8.27 (14.33%)

128

Buy

$92

$30.26 (49.01%)

$81

16 days ago
(08-Apr-2025)

2/8 (25%)

$34.27 (59.36%)

502

Buy

$80

$18.26 (29.58%)

$70

16 days ago
(08-Apr-2025)

3/10 (30%)

$22.27 (38.58%)

33

Buy

$91

$29.26 (47.39%)

$52

17 days ago
(07-Apr-2025)

11/12 (91.67%)

$36.04 (65.57%)

364

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is RYTM (Rhythm Pharmaceuticals) average time for price targets to be met?

On average it took 364.71 days on average for the stock forecasts to be realized with a an average price target met ratio 70.85

Which analyst has the current highest performing score on RYTM (Rhythm Pharmaceuticals) with a proven track record?

WHITNEY IJEM

Which analyst has the most public recommendations on RYTM (Rhythm Pharmaceuticals)?

Whitney Ijem works at CANACCORD and has 19 price targets and 10 ratings on RYTM

Which analyst is the currently most bullish on RYTM (Rhythm Pharmaceuticals)?

Whitney Ijem with highest potential upside - $30.26

Which analyst is the currently most reserved on RYTM (Rhythm Pharmaceuticals)?

Graig Suvannavejh with lowest potential downside - -$50.69

Rhythm Pharmaceuticals in the News

RYTM Stock Rises 17% on Meeting Goals in Hypothalamic Obesity Study

Shares of Rhythm Pharmaceuticals RYTM rallied 17.1% on Monday after the company announced that it has met the primary endpoint in a late-stage study of its candidate, setmelanotide, for treating acquired hypothalamic obesity. RYTM’s setmelanotide is an MC4R agonist. Per the data readout, the phase III TRANSCEND study met its primary endpoint with a statistically significant and...

Rhythm Pharmaceuticals (RYTM) Surges 17.1%: Is This an Indication of Further Gains?

Rhythm Pharmaceuticals, Inc. (RYTM) shares ended the last trading session 17.1% higher at $54.96. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock’s 7.6% loss over the past four weeks. The stock price rally was observed after RYTM announced meeting the...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?